Eddie Joe Sullivan - Jul 15, 2024 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
PRESIDENT, Director
Signature
/s/ Eddie Joe Sullivan
Stock symbol
SABS
Transactions as of
Jul 15, 2024
Transactions value $
$0
Form type
4
Date filed
7/17/2024, 04:30 PM
Previous filing
Feb 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Stock Option (right to buy) Award $0 +46.5K $0.00 46.5K Jul 15, 2024 Common Stock 46.5K $5.40 Direct F1, F3
transaction SABS Stock Option (right to buy) Award $0 +4.45K $0.00 4.45K Jul 15, 2024 Common Stock 4.45K $2.90 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a one-time grant to the Reporting Person as a member of the Board of Directors of the Issuer (the "Board"). Shares underlying the option are fully vested.
F2 Represents a one-time grant to the Reporting Person as a member of the Board. Shares underlying the option vest 25% on July 15, 2025, and in equal monthly installments thereafter over a three-year period ending July 15, 2028.
F3 This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.